Literature DB >> 26823774

KIR2DL4 expression rather than its single nucleotide polymorphisms correlates with pre-eclampsia.

Dandan Wang1, Yuan Tian1, Yanhui Zhao1, Lianlian Liu1, Xianying Liu1, Fuju Wu1.   

Abstract

OBJECTIVE: To evaluate the single nucleotide polymorphisms and expression of KIR2DL4 (killer cell immunoglobulin-like receptors) gene in pre-eclampsia patients.
METHODS: KIR2DL4 gene polymorphisms were detected in 100 patients with pre-eclampsia and 100 healthy pregnant women, respectively, by using PCR-SS. Then, the expression of KIR2DL4 was measured in 5 cases of placentas tissues with pre-eclampsia and normal pregnancies by using qRT-PCR.
RESULTS: Compared with healthy controls, 16 loci of single nucleotide polymorphisms (SNP) were identified in pre-eclampsia patients, including 7 new polymorphisms loci. But, no significant difference was found in genotype distributions and allele frequencies in pre-eclampsia and controls (P>0.05). However, qRT-PCR results showed that KIR2DL4 mRNA in placenta tissues with pre-eclampsia was significantly lower than those with normal pregnancy, and the difference was statistically significant.
CONCLUSION: Decreased level of KIR2DL4 rather than its SNP is correlated with the susceptibility of pre-eclampsia.

Entities:  

Keywords:  KIR2DL4; pre-eclampsia; single nucleotide polymorphisms; susceptibility

Mesh:

Substances:

Year:  2015        PMID: 26823774      PMCID: PMC4713560     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

Review 1.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

2.  Analysis of gene expression and preliminary study of methylation about 11β-HSD2 gene in placentas of Chinese pre-eclampsia patients of Han ethnicity.

Authors:  Wensheng Hu; Hanzhi Wang; Hefeng Huang
Journal:  J Obstet Gynaecol Res       Date:  2014-10-20       Impact factor: 1.730

3.  Doppler flowmetry of ophthalmic arteries for prediction of pre-eclampsia.

Authors:  Larissa Oliveira de Aquino; Henrique Vítor Leite; Antônio Carlos Vieira Cabral; Augusto Henriques F Brandão
Journal:  Rev Assoc Med Bras (1992)       Date:  2014 Nov-Dec       Impact factor: 1.209

4.  Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells.

Authors:  Guangjin Li; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Leukoc Biol       Date:  2008-06-27       Impact factor: 4.962

5.  Correlation between MTHFR gene methylation and pre-eclampsia, and its clinical significance.

Authors:  J Ge; J Wang; F Zhang; B Diao; Z F Song; L L Shan; W Wang; H J Cao; X Q Li
Journal:  Genet Mol Res       Date:  2015-07-17

6.  The genotype of the NK cell receptor, KIR2DL4, influences INFgamma secretion by decidual natural killer cells.

Authors:  J P Goodridge; L J Lathbury; E John; A K Charles; F T Christiansen; C S Witt
Journal:  Mol Hum Reprod       Date:  2009-06-09       Impact factor: 4.025

7.  Pre-eclampsia and first-onset postpartum psychiatric episodes: a Danish population-based cohort study.

Authors:  V Bergink; T M Laursen; B M W Johannsen; S A Kushner; S Meltzer-Brody; T Munk-Olsen
Journal:  Psychol Med       Date:  2015-08-05       Impact factor: 7.723

8.  The elucidation of KIR2DL4 gene polymorphism.

Authors:  Jennifer Schellekens; Marcel G J Tilanus; Erik H Rozemuller
Journal:  Mol Immunol       Date:  2007-12-21       Impact factor: 4.407

9.  KIR2DL4 (CD158d): An activation receptor for HLA-G.

Authors:  Sumati Rajagopalan; Eric O Long
Journal:  Front Immunol       Date:  2012-08-20       Impact factor: 7.561

10.  Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.

Authors:  Ilona Hromadnikova; Petra Pirkova; Lucie Sedlackova
Journal:  Mediators Inflamm       Date:  2013-02-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.